AxoGen Inc (AXGN)

8.35
0.00 (0.00)
NASDAQ : Health Care
Prev Close 8.35
Open 8.35
Day Low/High 8.30 / 8.55
52 Wk Low/High 3.26 / 7.97
Volume 201.07K
Avg Volume 186.10K
Exchange NASDAQ
Shares Outstanding 32.90M
Market Cap 277.99M
EPS -0.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

AXGN Crosses Above Average Analyst Target

AXGN Crosses Above Average Analyst Target

In recent trading, shares of AxoGen Inc have crossed above the average analyst 12-month target price of $8.25, changing hands for $8.55/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

AxoGen, Inc. Reports Financial Results For Third Quarter 2016

AxoGen, Inc. Reports Financial Results For Third Quarter 2016

Record revenues of $11.2 million, continued growth in accounts, and increased presence of nerve repair at key medical meetings    

AxoGen, Inc. Announces The Refinancing Of Its Debt Facility

AxoGen, Inc. Announces The Refinancing Of Its Debt Facility

New Agreement Will Replace Existing $25 million Term Loan and Revenue Interest Royalty Agreement, and Reduce Annual Interest Costs by at Least $1.5 Million

Commit To Purchase AxoGen At $7.50, Earn 17.1% Annualized Using Options

Commit To Purchase AxoGen At $7.50, Earn 17.1% Annualized Using Options

Investors considering a purchase of AxoGen Inc stock, but cautious about paying the going market price of $8.77/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the April 2017 put at the $7.50 strike, which has a bid at the time of this writing of 70 cents.

AxoGen, Inc. Appoints Amy Wendell To Board Of Directors  

AxoGen, Inc. Appoints Amy Wendell To Board Of Directors  

Former Covidien Senior Executive Brings More Than 30 Years of Experience to AxoGen Board

AxoGen To Participate At 71st Annual American Society For Surgery Of The Hand Meeting

AxoGen To Participate At 71st Annual American Society For Surgery Of The Hand Meeting

Expanded Role of Nerve Awareness and Repair in 30 Separate Conference Sessions and Presentations

AxoGen, Inc. To Participate At The American Association Of Oral And Maxillofacial Surgeons 98th Annual Meeting

AxoGen, Inc. To Participate At The American Association Of Oral And Maxillofacial Surgeons 98th Annual Meeting

Increasing Awareness of Nerve Injury and Repair in Multiple Conference Presentations

AxoGen, Inc. Reports Financial Results For Second Quarter 2016

AxoGen, Inc. Reports Financial Results For Second Quarter 2016

Second Quarter Revenues of $10.4M grew 62% over prior year

AxoGen Becomes Oversold (AXGN)

AxoGen Becomes Oversold (AXGN)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

3 Stocks Under $10 to Trade for Breakouts

3 Stocks Under $10 to Trade for Breakouts

These under-$10 stocks are within range of triggering breakout trades.

3 Stocks Advancing The Health Services Industry

3 Stocks Advancing The Health Services Industry

TheStreet highlights 3 stocks that pushed the Health Services industry

3 Stocks Pushing The Health Services Industry Lower

3 Stocks Pushing The Health Services Industry Lower

TheStreet highlights 3 stocks pushing the Health Services industry lower today.

3 Stocks Pushing The Health Services Industry Lower

3 Stocks Pushing The Health Services Industry Lower

TheStreet highlights 3 stocks pushing the Health Services industry lower today.

Frost & Sullivan Applaud AxoGen's Proprietary Process For Producing Decellularized Nerve Allografts

Frost & Sullivan Applaud AxoGen's Proprietary Process For Producing Decellularized Nerve Allografts

AxoGen is the only regenerative medicine company that is completely focused on peripheral nerve repair

AxoGen, Inc. Reports Record 2012 Revenues

AxoGen, Inc. Reports Record 2012 Revenues

AxoGen, Inc. (OTCBB: AXGN) a leading regenerative medicine company focused on the commercialization of proprietary products and technologies for peripheral nerve reconstruction and regeneration, today reported revenues...

AxoGen, Inc. Announces Release Date Of 2012 Fourth Quarter & Year End Results And Conference Call

AxoGen, Inc. Announces Release Date Of 2012 Fourth Quarter & Year End Results And Conference Call

AxoGen, Inc. (OTCBB: AXGN), a leading regenerative medicine company focused on the commercialization of proprietary products and technologies for peripheral nerve reconstruction and regeneration, today announced that...